The neutralization relationship of HIV type 1, HIV type 2, and SIVcpz is reflected in the genetic diversity that distinguishes them

AIDS Research and Human Retroviruses

Volumn 13, Issue 1, 1997, Pages 7-17

  Nyambi, Phillipe N ^a   Willems, Betty ^a   Janssens, Wouter ^a   Fransen, Katrien ^a   Nkengasong, John ^a   Peeters, Martine ^b   Vereecken, Katleen ^a   Heyndrickx, Leo ^a   Piot, Peter ^a   Van Der Groen, Guido ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS GENE; VIRUS ISOLATION;

EID: 0031031078     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1997.13.7     Document Type: Article

References (51)

1. Guyader M, Emerman M, Sonigo P, Clavel F, Montagnier L, and Alizon M: Genome organization and transactivation of the human immunodeficiency virus type 2. Nature (London) 1987;326: 662-669.
2. Clavel F, Guetard D, Brun-Vezinet F, Chamaret S, Rey M-A, Santos-Ferreira MO, Laurent AG, Dauguet C, Katlama C, Rouzioux C, Klatzmann D, Champalimaud JL, and Montaigner L: Isolation of a new human retrovirus from West African patients with AIDS. Science 1986;233:343-346.
3. Clavel F: HIV-2, the West African AIDS virus. AIDS 1987;1:135-140.
4. Brun-Vezinet F, Rey MA, Katlama C, Girard PM, Roulot D, Yeni P, Lenoble L, Clavel F, Alizon M, Gadelle S, Madjar JJ, and Harzic M: Lymphadenopathy-associated virus type 2 in AIDS and AIDS-related complex. Lancet 1987;1:128-132.
5. Albert J, Bredberg U, Chiodi F, Böttiger B, Fenyö EM, Norrby E, and Biberfeld G: A new human retrovirus isolate of West African origin (SBL-6669) and its relationship to HTLV-IV, LAV-II, and HTLV-IIIB. AIDS Res Hum Retroviruses 1987;3(1):3-10.
6. Hoxie JA: Hypothetical assignment of intrachain disulfide bonds for HIV-2 and SIV envelope glycoproteins. AIDS Res Hum Retroviruses 1991;7:495-499.
7. Gao F, Yue L, White AT, et al.: Human infection by genetically diverse SIVsm-related HIV-2 in West Africa. Nature (London) 1992;358:495-499.
8. Miura T, Sakuragi J-I, Kawamura M, et al.: Establishment of a phylogenetic survey system for AIDS-related lentiviruses and demonstration of a new HIV-2 subgroup. AIDS 1990;4:1257-1261.
9. Ho DD, Lee S, Moudgil T, and Kerndt PR: HIV-2 in Los Angeles. AIDS 1990;4:1301-1302.
10. Boeri E, Giri A, Lillo F, et al.: In vivo genetic variability of the human immunodeficiency virus type 2 V3 region. J Virol 1992;66:4546-4550.
11. Gao F, Yue L, Sharp PM, and Hahn BH: Genetic typing of HIV-2 from a Senegalese/German heterosexual transmission. AIDS Res Hum Retroviruses 1993;9:703-704.
12. Barnett SW, Quiroga M, Werner A, Dina D, and Levy JA: Distinguishing features of an infectious molecular clone of the highly divergent and noncytopathic human immunodeficiency virus type 2 UC1 strain. J Virol 1993;67:1006-1014.
13. Chakrabarti L, Guyader M, Alizon M, Daniel MD, Desrosiers RC, Tiollais P, and Sonigo P: Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses. Nature (London) 1987;328:543-547.
14. Franchini G, Fargnoli KA, Giombini F, Jagodzinski D, DeRossi A, Bosch M, Biberfeld G, Fenyö EM, Albert J, Gallo RC, and Wong-Staal F: Molecular and biological characterization of a replication competent human immunodeficiency virus type 2 (HIV-2) proviral clone. Proc Natl Acad Sci USA 1989;86:2433-2437.
15. Franchini G, Gurgo C, Guo HG, Gallo RC, Collati E, Fargnoli KA, Hall LF, Wong-Staal F, and Reitz MS Jr: Sequence of simian immunodeficiency virus and its relationship to the human immunodeficiency viruses. Nature (London) 1987;328:539-542.
16. Hirsch VM, Riedel N, and Mullins JI: The genome organization of STLV-3 is similar to that of the AIDS virus except for a truncated transmembrane protein. Cell 1987;49:307-319.
17. Huet T, Cheynier R, Meyerhans A, Roelants G, and Wain-Hobson S: Genetic organization of a chimpanzee lentivirus related to HIV-1. Nature (London) 1990;345:356-359.
18. Peeters M, Honoré C, Huet T, Bedjabaga L, Ossari S, Bussi P, Cooper RW, and Delaporte E: Isolation and partial characterization of an HIV-related virus occurring naturally in chimpanzees in Gabon. AIDS 1989;3:625-630.
19. Peeters M, Janssens W, Vanden Haesevelde M, Fransen K, Willems B, Heyndrickx L, Kestens L, Piot P, van der Groen G, and Heeney J: Virologic and serologic characteristics of a natural chimpanzee lentivirus infection. Virology 1995;211:312-315.
20. Nyambi PN, Nkengasong J, Peeters M, Simon F, Eberle J, Janssens W, Fransen K, Willems B, Vereecken K, Heyndrickx L, Piot P, and van der Groen G: Reduced capacily of antibodies from patients infected with human immunodeficiency virus type 1 (HIV-1) group O to neutralize primary isolates HIV-1 group M viruses. J Infect Dis 1995;172:1228-1237.
21. Nyambi PN, Nkengasong J, Lewi P, Andries K, Janssens W, Fransen K, Heyndrickx L, Piot P, and van der Groen G: Multivariate analysis of human immunodeficiency virus type 1 neutralization data. J Virol 1996;70:6235-6343.
22. Kostrikis LG, Cao Y, Ngai H, Moore JP, and Ho DD: Quantitative analysis of serum neutralization of human immunodeficiency virus type 1 from subtypes A, B, C, D, E, F and I: Lack of direct correlation between neutralizalion serotypes and genetic subtypes and evidence for prevalent serum-dependent infectivity enhancement. J Virol 1996;70:445-458.
23. Moore JP, Cao Y, Leu J, Qin L, Korber B, and Ho DD: Inter- and intraclade neutralization of human immunodeficiency virus type 1: Genetic clades do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes. J Virol 1996;70:427-444.
24. Böttiger B, Karlsson A, Andreasson P-A, Naucler A, Costa CM, and Biberfeld G: Cross-neutralizing antibodies against HIV-1 (HTLV-IIIB and HTLV-IIIRF) and HIV-2 (SBL-6669 and a new isolate SBL-K135). AIDS Res Hum Retroviruses 1990;5:525-533.
25. Böttiger B, Karlsson A, Andreasson P-A, Nauclér A, Costa CM, Norrby E, and Biberfeld G: Envelope cross-reactivity between human immunodeficiency virus types 1 and 2 detected by different serological methods: Correlation between cross-neutralization and reactivity against the main neutralizing site. J Virol 1990; 64:3492-3499.
26. Weiss RA, Clapham PR, Weber JN, Whitby D, Tedder RS, O'Connor T, Chamaret S, and Montagnier L: HIV-2 antisera cross-neutralize HIV-1. AIDS 1982;2:95-100.
27. Robert-Guroff M, Aldrich K, Muldoon R, Stern TL, Bansal GP, Matthews TJ, Markham PD, Gallo RC, and Franchini G: Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolates. J Virol 1992;66:3602-3608.
28. World Health Organization: WHO case definitions for AIDS surveillance in adults and adolescents. Wkly Epidemiol Rec 1994;69:273-275.
29. Peeters M, Gershy-Damet GM, Fransen K, et al.: Virological and polymerase chain reaction studies of HIV-1/HIV-2 dual infection in Côte d'Ivoire. Lancet 1992;340:339-340.
30. Sawyer LSW, Wrin MT, Crawford-Miksza, et al.: Neutralization sensitivity of HIV-1 is determined in part by the cell in which the virus is propagated. J Virol 1994;68:1342-1349.
31. IIB in sera of African and Belgian HIV-1-infected individuals. AIDS 1994;8:1089-1096.
32. Peeters M, Janssens W, Fransen K, Brandful J, Heyndrickx L, Koffi K, Delaporte E, Piot P, Gershy-Damet G-M, and van der Groen G: Isolation of simian immunodeficiency viruses from two sooty mangabeys in Côte d'Ivoire: Virological and genetic characterization and relationship to other HIV type 2 and SIVsm/mac strains. AIDS Res Hum Retroviruses 1994;10:1289-1294.
33. Van de Peer Y and De Wachter R: TREECON for Windows: A software package for the construction and drawing of evolutionary trees for the Microsoft Windows environment. Comput Applic Biosci 1994;10:569-570.
34. ANT70 isolate in human sera from different geographical origin. AIDS 1994;8:1657-1661.
35. Myers G, Korber B, Hahn BH, Jeang K-T, Mellors J-W, McCutchan FE, Henderson LE, and Pavlakis GN: Human Retroviruses and AIDS Database. Los Alamos National Laboralory, Los Alamos, New Mexico, 1995.
36. Robertson F, Sharp PM, McCutchan FE, and Hahn BH: Recombination in HIV-1. Nature (London) 1995;374:124-126.
37. Salminen M, Nykänen A, Brummer-Korvenkontio H, Kantanen ML, Liitsola K, and Leinikki P: Molecular epidemiology of HIV-1 based on phylogenetic analysis of in vivo gag p7/p9 direct sequences. Virology 1993;195:185-194.
38. Groopman JE, Benz PM, Ferriani R, Mayer K, Allan JD, and Weymouth LA: Characterization of serum neutralization response to the human immunodeficiency virus (HIV). AIDS Res Hum Retroviruses 1987;3:71-85.
39. Böttiger B, Ljunggren K, Karlsson A, Krohn K, Fenyö E-M, Jondal M, and Biberfeld G: Neutralizing antibodies in relation to antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus type 1. Clin Exp Immunol 1988;73: 339-342.
40. vanden Haesevelde M, Peeters M, Jannes G, Janssens W, van der Groen G, Sharp PM, and Saman E: Sequence analysis of a HIV-1 related lentivirus isolated from a wild captured chimpanzee. Virology 1996;221:346-350.
41. Sharp PM, Robertson DL, Gao F, and Hahn BH: Origins and diversity of human immunodeficiency viruses. AIDS 1994;8(Suppl. 1):S27-S42.
42. Dalgleish AG, Chanh TC, Kennedy RC, Kanda P, Clapham PR, and Weiss RA: Neutralization of diverse HIV-1 strains by monoclonal antibodies raised against gp41 synthetic peptide. Virology 1988;165:209-215.
43. Goudsmit J, Boucher CAB, Meloen RH, Epstein LG, Smit L, van der Hoek L, and Bakker M: Human antibody response to a strain-specific HIV-1 gp120 epitope associated with cell fusion inhibition. AIDS 1988;2:157-164.
44. Javaherian K, Langlois AJ, McDanal C, Ross KL, Eckler LI, Jellis CL, Profy AT, Rusche JR, Bolognesi DP, Putney SD, and Matthews TJ: Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. Proc Natl Acad Sci USA 1989;86:6768-6772.
45. Matsushita S, Robert-Guroff M, Rusche J, Koito A, Hattori T, Javaherian K, Takatsuki K, and Putney S: Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope. J Virol 1988;62:2107-2114.
46. Palker TJ, Clark ME, Langlois AJ, Matthews TJ, Weinhold KJ, Randall RR, Bolognesi DP, and Haynes BF: Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides. Proc Natl Acad Sci USA 1988;85:1932-1936.
47. Broliden P-A, von Gegerfelt A, Clapham P, Rosen J, Fenyö EM, Wahren B, and Broliden K: Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins. Proc Natl Acad Sci USA 1992;89:461-465.
48. Luo L, Li Y, Cannon PM, Kim S, and Kang CY: Chimeric gag-V3 virus-like particles of human immunodeficiency virus induce virus-neutralizing antibodies. Proc Natl Acad Sci USA 1992;89: 10527-10531.
49. Rusche JA, Javaherian K, McDanal C, Petro J, Lynn DL, Grimaila R, Langlois A, Gallo RC, Arthur LO, Fischinger PJ, Bolognesi DP, Putney S, and Matthews TJ: Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. Proc Natl Acad Sci USA 1988;85:3198-3202.
50. Goudsmit J, Debouck C, Meloen R, Smit L, Bakker M, Asher DM, Wolff AV, Gibbs CJ, and Gajdusek DC: Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees. Proc Natl Acad Sci USA 1988;85:4478-4482.
51. Back NKT, Smit L, Dejong JJ, et al.: An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization. Virology 1994;2:431-438.